412.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
412.2.0.1 ð Cram Sheet
412.2.0.1.1 ð¥ é« yield 10
- CV #1 mortality men
- Lung CA #1 cancer death (PSA SDM 55-69)
- CRC 45-75 USPSTF
- BPH 50% age 60, 80% age 80
- BPH α-blocker (tamsulosin) + 5α-RI (finasteride/dutasteride)
- Tadalafil 5 mg daily for BPH + ED
- Andropause / LOH: confirm low T Ã 2 + symptomatic
- TRAVERSE 2023: TRT non-inferior CV
- Suicide 4x women
- ED window CV (3-5 yr precedes MI)
412.2.0.1.2 ð¢ å¿ è
| é ç® | æžå |
|---|---|
| Heart disease men rank | #1 |
| Lung CA men rank | #1 cancer death |
| BPH histologic 60 yr | 50% |
| BPH histologic 90 yr | 90% |
| AUA IPSS mild | 0-7 |
| AUA IPSS moderate | 8-19 |
| AUA IPSS severe | 20-35 |
| Total T cutoff | < 264-300 ng/dL |
| Suicide F:M | 4x more men |
| Lifetime prostate CA | ~ 1/8 |
| PSA SDM age | 55-69 |
412.2.0.2 â é« yield
412.2.0.2.1 BPH Treatment Quick
| Drug | Mechanism |
|---|---|
| Tamsulosin | α1A selective (less BP) |
| Alfuzosin | α1 |
| Terazosin / doxazosin | α1 (also BP) |
| Finasteride | 5α-reductase (Type 2) |
| Dutasteride | 5α-reductase (Type 1+2) |
| Tadalafil | PDE5 daily for BPH+ED |
| Mirabegron | β3 agonist for OAB component |
| Anticholinergic | OAB symptoms |
412.2.0.2.2 Surgery for BPH
- TURP (transurethral resection prostate) â gold standard
- Laser (HoLEP, GreenLight)
- Prostatic urethral lift (UroLift)
- Water vapor (Rezum)
- Open prostatectomy (very large)
- Indications: severe LUTS refractory, retention, recurrent UTI, hematuria, stone, renal failure
412.2.0.2.3 Cancer Screening Men
| Cancer | Recommendation |
|---|---|
| Lung | USPSTF 50-80 + 20 PY + quit < 15 yr |
| Prostate | SDM 55-69 (PSA + DRE) |
| CRC | 45-75 (FIT/colonoscopy) |
| Skin | Self-exam ABCDE; high-risk q1y |
| Testicular | Self-exam (no formal screening) |
412.2.0.3 ð¯ èªææª¢æž¬
- CV men rank? â #1 mortality
- Lung CA men rank? â #1 cancer death
- PSA SDM age? â 55-69
- CRC USPSTF age? â 45-75
- BPH α-blocker 1st? â Tamsulosin
- BPH 5α-RI? â Finasteride / dutasteride
- Tadalafil 5 mg daily? â BPH + ED
- AUA IPSS severe? â 20-35
- Andropause T cutoff? â < 264-300
- TRAVERSE result? â TRT non-inferior CV
- Suicide F:M? â 4x more men
- ED CV window? â 3-5 yr
- PSA elevation workup? â BPH/prostatitis/CA, MRI prostate, biopsy
- Pediatric LDCT? â No (adult criteria)
- HPV vaccine men? â †26 yr (ACIP); some up to 45
â ïž AI èçš¿ã